FIELD: molecular biology, microbiological and medicinal industries, pharmacy. SUBSTANCE: invention proposes recombinant DNA containing the complete sequence of staphylokinase and lider block consisting of 6 histidine residues. Strain of E. coli SA 9325 is a producer of recombinant protein containing the complete sequence of staphylokinase from S. aureus. Invention ensures to obtain highly active protein showing fibrinolytic activity. The yield of recombinant protein is 20-26% of total protein content. Invention can be used for development of drugs, in part, recombinant forms of staphylokinase. EFFECT: recombinant DNA indicated above, high yield and activity of recombinant protein. 3 cl, 5 dwg, 1 ex
Authors
Dates
2000-09-20—Published
1999-02-03—Filed